INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 230 filers reported holding INARI MED INC in Q2 2022. The put-call ratio across all filers is 2.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $424,179,299 | +14.3% | 6,485,922 | +1.6% | 0.01% | +20.0% |
| Q2 2023 | $371,270,760 | +6.4% | 6,385,806 | +13.0% | 0.01% | 0.0% |
| Q1 2023 | $348,958,678 | -3.2% | 5,652,068 | -0.3% | 0.01% | -9.1% |
| Q4 2022 | $360,455,115 | -8.4% | 5,671,100 | +4.7% | 0.01% | -15.4% |
| Q3 2022 | $393,404,000 | +27.0% | 5,415,796 | +18.8% | 0.01% | +30.0% |
| Q2 2022 | $309,867,000 | +47.3% | 4,557,530 | +96.4% | 0.01% | +66.7% |
| Q1 2022 | $210,347,000 | -0.6% | 2,320,690 | +0.1% | 0.01% | +20.0% |
| Q4 2021 | $211,632,000 | +17.2% | 2,318,735 | +4.2% | 0.01% | 0.0% |
| Q3 2021 | $180,500,000 | +7.4% | 2,225,664 | +23.6% | 0.01% | 0.0% |
| Q2 2021 | $168,030,000 | +42.7% | 1,801,335 | +63.7% | 0.01% | +66.7% |
| Q1 2021 | $117,763,000 | +127.6% | 1,100,590 | +85.7% | 0.00% | +50.0% |
| Q4 2020 | $51,743,000 | +37.5% | 592,758 | +8.7% | 0.00% | +100.0% |
| Q3 2020 | $37,636,000 | – | 545,303 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |